Welcome to our dedicated page for PROCTER & GAMBLE Co SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PROCTER & GAMBLE Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PROCTER & GAMBLE Co's regulatory disclosures and financial reporting.
Christine M. McCarthy, a director of Procter & Gamble Co. (PG), reports a grant of 236 Restricted Stock Units (RSUs) on 09/09/2025 under the Procter & Gamble 2019 Stock & Incentive Compensation Plan. The RSUs were granted with a reported price of $0 and include dividend equivalents converted into additional RSUs. Following the grant, Ms. McCarthy beneficially owns 14,946.5131 shares (reported as direct ownership). The filing is signed by an attorney-in-fact on 09/10/2025 and includes the plan-based award disclosure in the explanatory notes.
Terry J. Lundgren, a director of Procter & Gamble (PG), was awarded 220 restricted stock units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a $0 per-share price as dividend-equivalent RSUs and are reported as 220 units added to his holdings. Following the transaction, Mr. Lundgren beneficially owns a total of 43,397.6912 shares, which includes RSU dividend equivalents and shares from the issuer's dividend reinvestment plan. Additionally, 530 shares are reported as indirectly held by his spouse.
Joseph Jimenez, a director of Procter & Gamble Co. (PG), was granted 298 restricted stock units (RSUs) on 09/09/2025. The award is reported as having a $0 per-share price because it is a restricted grant rather than an open-market purchase. After the grant (which includes dividend equivalents credited as RSUs), Mr. Jimenez beneficially owns 34,100.9784 shares in total. The RSUs were awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Jimenez on 09/10/2025.
The Vanguard Group reported ownership of 235,208,844 shares of Procter & Gamble (PG), representing 10.04% of the outstanding common stock. Vanguard discloses it is an investment adviser (IA) organized in Pennsylvania and holds 0 sole voting power, 13,404,221 shares with shared voting power, 212,819,403 shares with sole dispositive power, and 22,389,441 shares with shared dispositive power. The filing is a Schedule 13G/A amendment dated August 29, 2025, signed September 8, 2025.
Vanguard states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Procter & Gamble; the filing lists client accounts as the ultimate beneficial owners where applicable.
Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble (PG), reported a sale of 1,000 shares of P&G common stock on 08/29/2025 at $156.835 per share. After the sale she beneficially owned 28,435.8354 shares directly and 6,477.4515 shares indirectly via a retirement plan trustee. The Form 4 was executed by an attorney-in-fact.
The Procter & Gamble Company proxy statement describes board and governance practices, executive compensation design, and planned leadership transition. The Board comprises an independent majority and conducts annual director elections, regular executive sessions, and ongoing shareholder engagement including 75+ meetings in 2024-25. The compensation program emphasizes pay-for-performance with multi-year equity (PSPs, LTIP, RSUs), diversified performance metrics (organic sales growth, core EPS, operating profit, free cash flow) and a Relative TSR multiplier. The Compensation & Leadership Development Committee sets peer benchmarks, engages an independent consultant, enforces share ownership and clawback policies, and discloses that the 2024-25 Say-on-Pay received over 90% support. The filing notes a $1.0 billion after-tax impairment charge related to Gillette intangible assets and describes insider trading, related-person transaction, and equity plan provisions.
Form 144 notice for Procter & Gamble Company (PG) shows a proposed sale of 1,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $156,460. The filer reports acquiring 15,811 shares as a Performance Stock Program Award from Procter & Gamble and intends the sale approximately on 08/29/2025. The filing also discloses that the filer sold 6,167 shares for gross proceeds of $969,907.53. The notice includes the signed representation that the seller is unaware of undisclosed material adverse information about the issuer.
Procter & Gamble officer Moses Aguilar reported acquisitions of company common stock and restricted stock units. On 08/19/2025 he acquired 15,314 shares at $0 under the issuer's 2019 Stock and Incentive Compensation Plan, bringing his total direct beneficial ownership to 40,841.1704 shares. Additional indirect holdings include 6,750.7456 shares held by a retirement plan trustee and 428.6033 shares held by a Mexico international stock ownership plan trustee. The filing notes the report was late due to an inadvertent administrative error.
Insider sale to cover taxes. Procter & Gamble officer Sundar G. Raman reported a sale of 9,554 shares of PG on 08/21/2025 at an average price of $158.1589 per share to cover taxes related to a stock award. Following the reported sale the filing shows 41,886.4892 shares held directly and an additional 8,366.3969 shares held indirectly through a retirement plan trustee. The Form 4 was signed via attorney-in-fact on 08/22/2025. The filing identifies the reporting person as an officer (CEO-Fabric & Home Care).
Gary A. Coombe, an officer (CEO - Grooming) of Procter & Gamble Co (PG), reported a sale of 10,194 shares of P&G common stock on 08/21/2025 at a price of $158.159 per share. After the sale, Mr. Coombe's direct beneficial ownership is reported as 34,978.145 shares. He also reports indirect holdings of 477.661 shares held by a retirement plan trustee and 1,295.35 shares held in an International Stock Ownership Plan and Pension Plan (Switzerland). The filing states the shares were sold to cover taxes on a stock award. The form was signed by an attorney-in-fact on behalf of Mr. Coombe on 08/22/2025.